Oncolytics Biotech Inc T.ONC

KWSdeluxe --care to elaborate on your price prediction???

[HCallahann44]

I love your posts...and can only dream that we would be taken out for a premium like 15 to 25 billion...but what is the rationale? If PR can be used with all types of cancer and licensed to all the companies with CI drugs...maybe that would drive the valuation???

[Kswdelux]

The $15-$25B is based on comparisons to other recent companies bought out, cannot remember names right now, but they did not even have 1 biomarker and went for $8-$10B, and they were more specific to one cohort.  Pelareorep appears to be working across many cancer cohorts not just BC and has two biomarkers. A while back, I actual tried to do my own calculation based on number of BC

[canadafan]

FYI for those curious  the ps price is roughly $16/ billion of buy- out... that is USA$ btw. roughly $20ps CDN/ billion. Onc has traded as high as $60 usd , Way back. a $3 billion buy out would bring that easy. I do not think we are at the buy out stage yet. I do think, there will be either or both announced this year,. 1. a stage 3 enrolment/ partnership with $$ attached.( Mac) 2 a longer

[Kswdelux]

Agreed... we will see something significant in 2021. I am looking to Roche Could be an exciting week next week.

[checkup]

This post has been removed in accordance with Community Policy

[Kswdelux]

That is not my understanding. Look at the ONC Website that was updated March 5th, 2021. https://ir.oncolyticsbiotech.com/press-releases/detail/529/oncolytics-biotech-reports-fourth-quarter-and-full-year It states - Strong financial foundation with approximately $50 million in cash on hand and cash runway to H2 2022 They just sold a bunch of shares through the previous share sale agreement.

[checkup]

This post has been removed in accordance with Community Policy

[DaveE92]

 TD  shows 5 analysts with prices from 6.00 to 18.84. the high price was reiterated March 22/21.

[Kswdelux]

Interesting. I have not seen the $18.84 Target price yet.   Just as a note, the analysts do their projections on general anticipated growth of the company. Their projections (target prices) do not take into account exceptional news. Anything significant in the April 10th-12th 2021 AACR could send this up significantly. Nothing really significant and it will drop for a while then start to

[Kswdelux]

Then again.... Today looks like it is profit taking day.  Guess they are Selling high... locking in profits Selling it down... and buying back in at a lower price. I expect to start seeing this start to go back up later in the day.

[HARJAY]

from TD  FYI Valuation as of 7 Apr 2021 Fair  9.44  Last Close 5.80 ONC is Under Valued at a 37% discount